STIA007
The percentage of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record in the preceding 12 months that an anti-platelet agent, or an anti-coagulant is being taken
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 12 | 2011 | 2542 | 2745 | 92.6% | |
| STROKE 12 | 2012 | 2600 | 2806 | 92.7% | |
| STROKE 12 | 2013 | 2450 | 2634 | 93.0% | |
| STIA007 | 2014 | 2509 | 2603 | 96.4% | |
| STIA007 | 2015 | 2496 | 2563 | 97.4% | |
| STIA007 | 2016 | 2469 | 2533 | 97.5% | |
| STIA007 | 2017 | 2479 | 2545 | 97.4% | |
| STIA007 | 2018 | 2527 | 2610 | 96.8% | |
| STIA007 | 2019 | 2610 | 2693 | 96.9% | |
| STIA007 | 2020 | 2681 | 2779 | 96.5% | |
| STIA007 | 2021 | 2623 | 2963 | 88.5% | |
| STIA007 | 2022 | 2726 | 2915 | 93.5% | |
| STIA007 | 2023 | 2799 | 2889 | 96.9% |
